top of page

ASCO 2026: Nanobiotix's approach to boosting the efficacy of radiation therapy is in a P3 head & neck trial that JNJ is leading, and they are expecting a key P2 readout in lung before it as well

  • May 29
  • 1 min read

CEO Laurent Lévy walks us through the phase 3 trial's progress, and the reason why the trial protocol was recently changed. Plus, how this nano approach is looking in other cancers, and how Nanobiotix is also trying to help make LNP delivered medicines have wider utility.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTV

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

Learn more

bottom of page